User profiles for F. Zhou

Fangfang zhou

- Verified email at mails.tsinghua.edu.cn - Cited by 8201

Feng Zhou

- Verified email at pku.edu.cn - Cited by 7173

Feng Zhou

- Verified email at gatech.edu - Cited by 6074

Trends in augmented reality tracking, interaction and display: A review of ten years of ISMAR

F Zhou, HBL Duh, M Billinghurst - 2008 7th IEEE/ACM …, 2008 - ieeexplore.ieee.org
Although Augmented Reality technology was first developed over forty years ago, there has
been little survey work giving an overview of recent research in the field. This paper reviews …

[HTML][HTML] SARS-CoV-2 Omicron variant: recent progress and future perspectives

…, X Li, L Zhang, S Wan, L Zhang, F Zhou - Signal transduction and …, 2022 - nature.com
Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, there have been
a few variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), one …

Catalytic asymmetric synthesis of oxindoles bearing a tetrasubstituted stereocenter at the C‐3 position

F Zhou, YL Liu, J Zhou - Advanced Synthesis & Catalysis, 2010 - Wiley Online Library
The 3,3′‐disubstituted oxindole structural motif is a prominent feature in many alkaloid
natural products, which include all kinds of tetrasubstituted carbon stereocenters, spirocyclic or …

[HTML][HTML] Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

F Zhou, T Yu, R Du, G Fan, Y Liu, Z Liu, J Xiang… - The lancet, 2020 - thelancet.com
Background Since December, 2019, Wuhan, China, has experienced an outbreak of
coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome …

[HTML][HTML] A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19

…, F Gong, Y Liu, Y Wei, C Dong, F Zhou… - New England journal …, 2020 - Mass Medical Soc
Background No therapeutics have yet been proven effective for the treatment of severe
illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label …

[HTML][HTML] Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

…, Y Ye, B Liu, J Yang, W Yin, A Wang, G Fan, F Zhou… - The lancet, 2020 - thelancet.com
Background No specific antiviral drug has been proven effective for treatment of patients
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …

Identification of the von Hippel-Lindau disease tumor suppressor gene

…, L Geil, L Schmidt, F Zhou, H Li, MH Wei, F Chen… - Science, 1993 - science.org
A gene discovered by positional cloning has been identified as the von Hippel-Lindau (VHL)
disease tumor suppressor gene. A restriction fragment encompassing the gene showed …

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

…, X Zhou, D Chen, W Xiong, L Xu, F Zhou… - JAMA internal …, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that
was first reported in Wuhan, China, and has subsequently spread worldwide. Risk factors for …

Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak

M Dai, D Liu, M Liu, F Zhou, G Li, Z Chen, Z Zhang… - Cancer discovery, 2020 - AACR
Because this is the first large cohort study on this topic, our report will provide much-needed
information that will benefit patients with cancer globally. As such, we believe it is extremely …

A comprehensive quantification of global nitrous oxide sources and sinks

…, GP Peters, H Shi, FN Tubiello, S Zaehle, F Zhou… - Nature, 2020 - nature.com
Nitrous oxide (N 2 O), like carbon dioxide, is a long-lived greenhouse gas that accumulates
in the atmosphere. Over the past 150 years, increasing atmospheric N 2 O concentrations …